Literature DB >> 10739896

3-Nitropropionic acid preconditioning ameliorates delayed neurological deterioration and infarction after transient focal cerebral ischemia in gerbils.

T Kuroiwa1, I Yamada, S Endo, Y Hakamata, U Ito.   

Abstract

The effect of 3-nitropropionic acid (3-NP), a selective inhibitor of succinic dehydrogenase, preconditioning on postischemic neurological deterioration and infarction was examined in gerbils after transient ischemia. The animals were pretreated with 1-80mg/kg of 3-NP 1 day before ischemia induced by two 10-min occlusions of the left common carotid artery. Four milligrams per kilogram 3-NP pretreatment significantly ameliorated postischemic neurological deterioration (stroke index at 7 days postischemia, 1.4+/-1.5 vs. 7.4+/-5.4 in 4 mg/kg-pretreated vs. non-pretreated animals: mean+/-SD) and reduced infarct volume (24+/-4.8 vs. 43+/-12 mm(3)). One and 20 mg/kg 3-NP induced milder neuroprotection, and 80 mg/kg 3-NP aggravated postischemic stroke symptoms and infarction. Thus, appropriate doze of 3-NP preconditioning is effective in ameliorating the postischemic neurological deterioration and reducing infarct volume.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10739896     DOI: 10.1016/s0304-3940(00)00937-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

2.  Evidence for a role of second pathophysiological stress in prevention of delayed neuronal death in the hippocampal CA1 region.

Authors:  Jozef Burda; Milina Matiasová; Miroslav Gottlieb; Viera Danielisová; Miroslava Némethová; Lidia Garcia; Matilde Salinas; Rastislav Burda
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

3.  Cerebral ischemic tolerance induced by 3-nitropropionic acid is associated with increased expression of erythropoietin in rats.

Authors:  Hongcan Zhu; Shenggang Sun; Hongge Li; Yuming Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Rapid ischemic tolerance induced by adenosine preconditioning results in Bcl-2 interacting mediator of cell death (Bim) degradation by the proteasome.

Authors:  Andrea Nicole Ordonez; Veronica Joy Jessick; Corrin Erin Clayton; Michelle Dawn Ashley; Simon John Thompson; Roger Pancoast Simon; Robert Meller
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-01-01

5.  Role of protein synthesis in the ischemic tolerance acquisition induced by transient forebrain ischemia in the rat.

Authors:  Jozef Burda; Milina Hrehorovská; Lidia García Bonilla; Viera Danielisová; Dása Cízková; Rastislav Burda; Miroslava Némethová; Juan L Fando; Matilde Salinas
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

6.  Inhibition of caspase-3 activation and apoptosis is involved in 3-nitropropionic acid-induced ischemic tolerance to transient focal cerebral ischemia in rats.

Authors:  Hong-Can Zhu; Xia-Qun Gao; Ying Xing; Sheng-Gang Sun; Hong-Ge Li; Yun-Fu Wang
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 7.  Global cerebral ischemia: synaptic and cognitive dysfunction.

Authors:  Jake T Neumann; Charles H Cohan; Kunjan R Dave; Clinton B Wright; Miguel A Perez-Pinzon
Journal:  Curr Drug Targets       Date:  2013-01-01       Impact factor: 3.465

Review 8.  Ischemic tolerance - blessing or curse.

Authors:  J Burda; R Burda
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881

Review 9.  Ischemic Tolerance of the Brain and Spinal Cord: A Review.

Authors:  Masatoshi Yunoki; Takahiro Kanda; Kenta Suzuki; Atsuhito Uneda; Koji Hirashita; Kimihiro Yoshino
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-09-27       Impact factor: 1.742

Review 10.  Hormesis: Path and Progression to Significance.

Authors:  Edward J Calabrese
Journal:  Int J Mol Sci       Date:  2018-09-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.